1
/
of
1
Co-Altria (Montelukast Sodium + Levocetirizine Hydrochloride)
Co-Altria (Montelukast Sodium + Levocetirizine Hydrochloride)
Regular price
₱1,140.00 PHP
Regular price
Sale price
₱1,140.00 PHP
Unit price
₱38.00 each
Taxes included.
Quantity
Couldn't load pickup availability
Co-Altria combines two powerful active ingredients—Montelukast Sodium and Levocetirizine Hydrochloride—to provide comprehensive relief from allergic conditions and asthma-related symptoms. This dual-action formulation targets both inflammatory pathways and histamine response, making it an effective choice for patients managing moderate to severe allergies.
Montelukast Sodium is a cysteinyl leukotriene receptor antagonist that works by blocking the action of leukotrienes, chemicals in the body that cause inflammation, airway constriction, and mucus production. This mechanism is particularly valuable for controlling asthma exacerbations triggered by allergens, exercise, or aspirin sensitivity.
Levocetirizine Hydrochloride is a selective H1-receptor antagonist that rapidly reduces itching, hives, sneezing, and nasal congestion associated with allergic rhinitis and urticaria. As the active enantiomer of cetirizine, levocetirizine offers faster onset and improved efficacy compared to its racemic parent compound.
The combination therapy in Co-Altria addresses multiple symptoms simultaneously: nasal obstruction, pruritus, rhinorrhea, and bronchial hyperresponsiveness. This integrated approach reduces the need for multiple medications and simplifies adherence for patients with overlapping allergic and asthmatic presentations.
Co-Altria is suitable for adults and children seeking sustained symptom management without the sedation commonly associated with first-generation antihistamines. The formulation provides consistent relief when taken as directed, allowing patients to maintain daily activities and quality of life while managing chronic allergic conditions.
Montelukast Sodium is a cysteinyl leukotriene receptor antagonist that works by blocking the action of leukotrienes, chemicals in the body that cause inflammation, airway constriction, and mucus production. This mechanism is particularly valuable for controlling asthma exacerbations triggered by allergens, exercise, or aspirin sensitivity.
Levocetirizine Hydrochloride is a selective H1-receptor antagonist that rapidly reduces itching, hives, sneezing, and nasal congestion associated with allergic rhinitis and urticaria. As the active enantiomer of cetirizine, levocetirizine offers faster onset and improved efficacy compared to its racemic parent compound.
The combination therapy in Co-Altria addresses multiple symptoms simultaneously: nasal obstruction, pruritus, rhinorrhea, and bronchial hyperresponsiveness. This integrated approach reduces the need for multiple medications and simplifies adherence for patients with overlapping allergic and asthmatic presentations.
Co-Altria is suitable for adults and children seeking sustained symptom management without the sedation commonly associated with first-generation antihistamines. The formulation provides consistent relief when taken as directed, allowing patients to maintain daily activities and quality of life while managing chronic allergic conditions.
Share
